methylene blue has been researched along with ecallantide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghahestani, SM; Karimi, S; Madani, MH; Shahab, E | 1 |
1 other study(ies) available for methylene blue and ecallantide
| Article | Year |
|---|---|
Methylene blue may have a role in the treatment of COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Aprotinin; Bradykinin; COVID-19 Drug Treatment; Cytokines; Humans; Kininogens; Methylene Blue; Models, Theoretical; Nitric Oxide; Nitric Oxide Synthase; Peptides; Renin-Angiotensin System | 2020 |